publicaciones seleccionadas artículo académico Evaluating the adjuvant potential of NK-lysin and HMGB1-derived peptides in enhancing immune responses in Salmo salar. FISH & SHELLFISH IMMUNOLOGY. 164. 2025 Design and functional characterization of Salmo salar TLR5 agonist peptides derived from high mobility group B1 acidic tail. FISH & SHELLFISH IMMUNOLOGY. 146. 2024 Development and characterization of a novel variant of long-acting bovine follicle-stimulating hormone (brscFSH). THERIOGENOLOGY. 226:76-86. 2024 Development of an indirect ELISA for the serologic detection of bovine viral diarrhea virus based on E2 antigen sub-genotypes 1b, 1e, and 1d. TROPICAL ANIMAL HEALTH AND PRODUCTION. 56(8). 2024 Multilayer Nanocarrier for the Codelivery of Interferons: A Promising Strategy for Biocompatible and Long-Acting Antiviral Treatment. PHARMACEUTICS. 16(11). 2024 New insight into the biological activity of Salmo salar NK-lysin antimicrobial peptides. FRONTIERS IN IMMUNOLOGY. 15. 2024 Recombinant Subunit Vaccine Candidate against the Bovine Viral Diarrhea Virus. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 25(16). 2024 Co-Formulation of Recombinant Porcine IL-18 Enhances the Onset of Immune Response in a New Lawsonia intracellularis Vaccine. VACCINES. 11(12). 2023 Immunomodulatory role of vasoactive intestinal peptide and ghrelin in Oncorhynchus mykiss. HELIYON. 9(12). 2023 New Formulation of a Subunit Vaccine Candidate against Lawsonia intracellularis Increases Humoral and Cellular Immune Responses. VACCINES. 11(12). 2023 A trivalent TNF-R2 as a new tumor necrosis factor alpha-blocking molecule. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS. 89(11):1557-1564. 2021 Characterisation of a new molecule based on two E2 sequences from bovine viral diarrhoea-mucosal disease virus fused to the human immunoglobulin Fc fragment. JOURNAL OF VETERINARY RESEARCH. 65(1):27-37. 2021 Establishment of a production process for a novel vaccine candidate against Lawsonia intracellularis. ELECTRONIC JOURNAL OF BIOTECHNOLOGY. 50:45-52. 2021 Expression and characterization of a novel single-chain anti-vascular endothelial growth factor antibody in the goat milk. JOURNAL OF BIOTECHNOLOGY. 338:52-62. 2021 In vivo modification of the goat mammary gland glycosylation pathway. NEW BIOTECHNOLOGY. 61:11-21. 2021 New insights on the interaction mechanism of rhTNFa with its antagonists Adalimumab and Etanercept. BIOCHEMICAL JOURNAL. 477(17):3299-3311. 2020 In vitro immunomodulatory activities of peptides derived from Salmo salar NK-lysin and cathelicidin in fish cells. FISH & SHELLFISH IMMUNOLOGY. 88:587-594. 2019 Multi-antigenic recombinant subunit vaccine against Lawsonia intracellularis: The etiological agent of porcine proliferative enteropathy. VACCINE. 37(10):1340-1349. 2019 Neuroprotective effect of a new variant of Epo nonhematopoietic against oxidative stress. REDOX BIOLOGY. 14:285-294. 2018 Quantitative ELISA sandwich for a new vaccine against avian influenza virus H5N1. JOURNAL OF IMMUNOLOGICAL METHODS. 459:70-75. 2018 Structural characterization and biological implications of sulfated N-glycans in a serine protease from the neotropical moth Hylesia metabus (Cramer [1775]) (Lepidoptera: Saturniidae). GLYCOBIOLOGY. 26(3):230-250. 2016 Post-translational modification of a chimeric EPO-Fc hormone is more important than its molecular size in defining its in vivo hematopoietic activity. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 1850(9):1685-1693. 2015